Explore more publications!

Texas Business Times: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Texas Business Times.

Press releases published on October 8, 2025

Milton Arch Celebrates Milestone with Dallas NFT Headquarters Expansion
HM&M Recognized as One of the Best Places to Work for Women
Tesla Outsourcing Services LLC Masters MEP Complexity, Engineering the Digital Heartbeat of Modern Buildings
American Receivable Continues to Fuel Small Business Growth—Still Adding $2 Million in Monthly Funding After 46 Years
ANDRITZ and GESA Forge Strategic Partnership to Deliver Best-in-Class Generator Services Across North America
Puerta del Lobo Breaks Ground on Landmark Texas Winery and Luxury Development
Bryant Group Launches RISE: A New Leadership Program Elevating Women in Advancement
Nilo Therapeutics se lanza con un financiamiento Serie A de 101 millones de dólares para avanzar una nueva clase de medicamentos dirigidos a los circuitos neuronales en enfermedades inmunológicas y nombra a Kim Seth como director ejecutivo
Lancement de Nilo Therapeutics avec un financement de série A de 101 millions de dollars en vue de développer une nouvelle classe de médicaments ciblant les circuits neuronaux dans les maladies immunitaires, et nomination de Kim Seth au poste de…
ナイロ・セラピューティクス (Nilo Therapeutics)、免疫疾患における神経回路を標的とする新しい種類の医薬品開発を推進するため、1億100万米ドル (約154億1,290万円) のシリーズA資金調達を実施し、キム・セス博士 (Kim Seth, Ph.D.) を最高経営責任者 (CEO) に任…
Nilo Therapeutics dilancarkan dengan pembiayaan Siri A sebanyak $101 juta untuk membangunkan kelas baharu ubat-ubatan yang menyasarkan litar neural dalam penyakit imun, serta melantik Kim Seth sebagai Ketua Pegawai Eksekutif
Nilo Therapeutics é lançada com financiamento de US $101 milhões da Série A para promover uma nova classe de medicamentos direcionados a circuitos neurais em doenças imunológicas e nomeia Kim Seth como CEO
Nilo Therapeutics 啟動 1.01 億美元 A 輪融資,推進針對免疫疾病神經迴路的新型藥物研發,並任命 Kim Seth 為行政總裁
Nilo Therapeutics เปิดตัวด้วยการระดมทุนรอบ Series A มูลค่าถึง 101 ล้านเหรียญสหรัฐ เพื่อพัฒนายาประเภทใหม่ที่มุ่งเป้าไปที่วงจรระบบประสาทในโรคภูมิคุ้มกัน รวมถึงแต่งตั้ง Kim Seth เป็นประธานเจ้าหน้าที่บริหา…
Nilo Therapeutics 启动 1.01 亿美元 A 轮融资,以推进靶向免疫疾病神经回路的新型药物研发,并任命 Kim Seth 为首席执行官
Wiggle Butt Academy Public‑Private Partnership Moves Forward with City of Frisco for State‑of‑the‑Art Animal Facility
AppFolio Data Breach Exposes Personal Information: Murphy Law Firm Investigates Legal Claims
Avidian Gold Corp. Files Early Warning Report in Respect of High Tide Resources Corp.
Collin County Property Tax Appeals Cut $7.89 Billion from Record Taxable Values
DeFi Development Corp. and Superteam Japan Announce Partnership to Launch DFDV JP, the First Solana Treasury Project in Japan

Share us

on your social networks:
AGPs

Get the latest news on this topic.

SIGN UP FOR FREE TODAY

No Thanks

By signing to this email alert, you
agree to our Terms & Conditions